137 related articles for article (PubMed ID: 35981838)
1. Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI.
Mauler-Wittwer S; Sievert H; Ioppolo AM; Mahfoud F; Carrié D; Lipiecki J; Nickenig G; Fajadet J; Eckert S; Morice MC; Garot P
JACC Cardiovasc Interv; 2022 Aug; 15(16):1639-1648. PubMed ID: 35981838
[TBL] [Abstract][Full Text] [Related]
2. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
Barbanti M; Gulino S; Capranzano P; Immè S; Sgroi C; Tamburino C; Ohno Y; Attizzani GF; Patanè M; Sicuso R; Pilato G; Di Landro A; Todaro D; Di Simone E; Picci A; Giannetto G; Costa G; Deste W; Giannazzo D; Grasso C; Capodanno D; Tamburino C
JACC Cardiovasc Interv; 2015 Oct; 8(12):1595-604. PubMed ID: 26386766
[TBL] [Abstract][Full Text] [Related]
3. Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial.
Bolt LJJ; Sigterman TA; Krasznai AG; Sikkink CJM; Schurink GH; Bouwman LH
BMJ Open; 2018 Oct; 8(9):e021842. PubMed ID: 30287607
[TBL] [Abstract][Full Text] [Related]
4. Effect of periprocedural furosemide-induced diuresis with matched isotonic intravenous hydration in patients with chronic kidney disease undergoing transcatheter aortic valve implantation.
Voigtländer-Buschmann L; Schäfer S; Schmidt-Lauber C; Weimann J; Shenas M; Giraldo Cortes J; Kuta PM; Zeller T; Twerenbold R; Seiffert M; Schofer N; Schneeberger Y; Schäfer A; Schirmer J; Reichenspurner H; Blankenberg S; Conradi L; Schäfer U
Clin Res Cardiol; 2024 Jun; 113(6):801-811. PubMed ID: 37264143
[TBL] [Abstract][Full Text] [Related]
5. Diuresis-matched versus standard hydration in patients undergoing percutaneous cardiovascular procedures: meta-analysis of randomized clinical trials.
Occhipinti G; Laudani C; Spagnolo M; Greco A; Capodanno D
Rev Esp Cardiol (Engl Ed); 2023 Oct; 76(10):759-766. PubMed ID: 36801376
[TBL] [Abstract][Full Text] [Related]
6. High-volume forced diuresis with matched hydration using the RenalGuard System to prevent contrast-induced nephropathy: A meta-analysis of randomized trials.
Shah R; Wood SJ; Khan SA; Chaudhry A; Rehan Khan M; Morsy MS
Clin Cardiol; 2017 Dec; 40(12):1242-1246. PubMed ID: 29247527
[TBL] [Abstract][Full Text] [Related]
7. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
8. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Napolitano G; Focaccio A;
Catheter Cardiovasc Interv; 2020 Apr; 95(5):895-903. PubMed ID: 31282129
[TBL] [Abstract][Full Text] [Related]
9. RenalGuard system and conventional hydration for preventing contrast-associated acute kidney injury in patients undergoing cardiac interventional procedures: A systematic review and meta-analysis.
Wang Y; Guo Y
Int J Cardiol; 2021 Jun; 333():83-89. PubMed ID: 33662483
[TBL] [Abstract][Full Text] [Related]
10. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
[TBL] [Abstract][Full Text] [Related]
11. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Contrast-Induced Acute Kidney Injury by Furosemide With Matched Hydration in Patients Undergoing Interventional Procedures: A Systematic Review and Meta-Analysis of Randomized Trials.
Putzu A; Boscolo Berto M; Belletti A; Pasotti E; Cassina T; Moccetti T; Pedrazzini G
JACC Cardiovasc Interv; 2017 Feb; 10(4):355-363. PubMed ID: 28231903
[TBL] [Abstract][Full Text] [Related]
13. RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study.
Katoh H; Nozue T; Horie K; Sozu T; Inoue N; Michishita I
Cardiovasc Interv Ther; 2019 Apr; 34(2):105-112. PubMed ID: 29730853
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
Dorval JF; Dixon SR; Zelman RB; Davidson CJ; Rudko R; Resnic FS
Int J Cardiol; 2013 Jun; 166(2):482-6. PubMed ID: 22204847
[TBL] [Abstract][Full Text] [Related]
15. [Monocentric experience of the RenalGuard® system to limit post-contrast acute kidney injury in patients at high-risk undergoing interventional coronary procedures].
Elleuch A; Hebbo A; Steinecker M; Bouaouina MS; Alqudwa A; Ghannem M; Poulos N; Aubry P
Ann Cardiol Angeiol (Paris); 2022 Nov; 71(5):283-289. PubMed ID: 36115720
[TBL] [Abstract][Full Text] [Related]
16. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
18. Forced diuresis with matched hydration in reducing acute kidney injury during transcatheter aortic valve implantation (Reduce-AKI): study protocol for a randomized sham-controlled trial.
Arbel Y; Ben-Assa E; Halkin A; Keren G; Schwartz AL; Havakuk O; Leshem-Rubinow E; Konigstein M; Steinvil A; Abramowitz Y; Finkelstein A; Banai S
Trials; 2014 Jul; 15():262. PubMed ID: 24986373
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
Qian G; Fu Z; Guo J; Cao F; Chen Y
JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
[TBL] [Abstract][Full Text] [Related]
20. RenalGuard system in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Donahue M; De Micco F; Focaccio A; Golia B; Signoriello G; Ciardiello C; Donnarumma E; Condorelli G
Am Heart J; 2016 Mar; 173():67-76. PubMed ID: 26920598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
